Search

Your search keyword '"Ahmed, Munaza"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Ahmed, Munaza" Remove constraint Author: "Ahmed, Munaza"
166 results on '"Ahmed, Munaza"'

Search Results

1. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

2. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

3. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

4. Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy

5. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

6. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

7. ALICE upgrades during the LHC Long Shutdown 2

8. Decision making for health‐related research outcomes that alter diagnosis: A model from paediatric brain tumours.

9. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.

10. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study

11. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

12. Benefits for children with suspected cancer from routine whole-genome sequencing

13. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

14. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants inBRCA1andBRCA2

15. 2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer

16. 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer

17. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements

18. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

19. Prevalence and architecture of de novo mutations in developmental disorders

20. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.

21. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.

22. Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews

23. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

24. Whole-genome sequencing of patients with rare diseases in a national health system

25. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

26. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

27. Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

28. Results from London Regional Clinical Genetics services over a 5-year period on germline TP53 testing in women diagnosed with breast cancer at <30 years

29. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

30. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study

31. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

32. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers:an international cohort study

33. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT):initial results from an international prospective study

34. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1and PALB2

35. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1and BRCA2

36. Results from London Regional Clinical Genetics services over a 5-year period on germline TP53 testing in women diagnosed with breast cancer at <30 years.

37. Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication

38. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

39. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

40. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

41. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

42. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

43. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

44. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

45. Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

46. Gene–gene interactions in breast cancer susceptibility

47. Prostate Cancer Risk by BRCA2 Genomic Regions

48. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention

49. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

50. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

Catalog

Books, media, physical & digital resources